Neuromod specialises in non-invasive treatment to help patients suffering with tinnitus

Neuromod, a healthcare start-up developing treatments for tinnitus, is in talks to raise up to €24m in investment.

Accounts just filed for the business state that the directors are in “advanced discussions with third-party investors” and are “confident of securing additional investment of €24m” in the coming months.

The accounts also state that Neuromod expects to start generating revenue in the first quarter of 2019 following a successful period of clinical trials.

Headquartered in Dublin’s Digital Hub, Neuromod specialises in non-invasive treatment to help patients suffering with tinnitus, a chronic clicking or buzzing in the ears which affects about 10% of the population.

“Building on the successful results of our large-scale multi-centre clinical trials, the company now plans to raise the capital to bring this